All News
EULAR 2024 – Day 3 Report
EULAR treats its attendees to a wonderful lunch each day – Schnitzel, gnocchi, goulash at lunch after muffins and coffee in the morning. It's no wonder the meeting has been a lively one, well attended with a wealth of stimulating ideas, research and discussion. Here are a few of my favorite abstracts and presentations from today, day 3 in Vienna.
Read Article
Matters of the heart: cardiovascular disease and mortality in RA
Two large retrospective cohort studies presented by the team at Mayo Clinic, Rochester MN examine the burden of stroke, as well as overall and cause-specific mortality in people with RA (POS0591 and POS0592).
Read Article
New reccs for knee/hip #OA w/2 overarching principles
1. Biopsychosocial approach
2.Individualized Rx w/shared decision making (includes education, diet/exercise, healthy weight, appropriate assistive device/footware, modify work factors, pain coping skills)
#EULAR24
@rheumnow https://t.co/0LVLBMGO7L
TheDaoIndex KDAO2011 ( View Tweet)
Thanks for these updates recommendations for hip/knee OA -- but, still not much has changed. #eular2034 https://t.co/NMwFWxwocF
Dr. John Cush RheumNow ( View Tweet)
AI meets Rheumatology: ChatGPT and patient response optimization
Large language models like ChatGPT, trained on vast text data, are revolutionizing healthcare by understanding and generating human-like language.
https://t.co/GzT9UvndTX https://t.co/ziOh8oCbZ9
Dr. John Cush RheumNow ( View Tweet)
@RheumNow The always erudite @LCalabreseDO is no slouch of a debating opponent, however. He acknowledges that the science has been imperfect, too much is wrapped up in it, and that fibromyalgia can teach a lot to long COVID. #EULAR2024 @RheumNow https://t.co/TzR4SMZh9f
Links:
David Liew drdavidliew ( View Tweet)
@RheumNow @LCalabreseDO @NIH and Len gives us some key recommendations for better practice for long COVID - for me, equally as applicable to fibromyalgia as to long COVID.
Fantastic discussion #EULAR2024 @RheumNow https://t.co/8PnjPEKcOu
David Liew drdavidliew ( View Tweet)
#IgG4 Pearls
Thanks for sharing
Isolated ⬆️ serum #IgG4 level
✅ How high? 5x ULN ➡️ PPV 75%
✅Typical organ(s) involved?
❓Another explanation
Dr Jone Stone
#Rheumatology #EULAR2024 https://t.co/UVKmH57iVM https://t.co/uxHBl0I3cM
Links:
Ask The Rheumatologist LastManStand85 ( View Tweet)
EULAR guidelines for screening for TB in rheumatic disease patients
#EULAR2024 https://t.co/jaixl8lGkY
Jilaine Bolek Berquist BolekBerqui ( View Tweet)
DMOADs in #osteoarthritis at #EULAR2024: 1) Tonia Vincent: StepUp OA endotype SF proteomics —> endothelial to mesenchymal transition proteins. 2) Phil Conaghan: proregenerative (& degeneration slowing) therapies in pipeline. 3) @Larhumato: novel RCT designs & structure outcomes
Tuhina Neogi, MD, PhD Tuhina_Neogi ( View Tweet)
Recommendation for management of fatigue in people with rheumatic disease.
Considering fatigue as a surrogate for inflammation and changing medication accordingly is part of it.
I will also add yearly blood work including:
1- VitD
2-HBA1c and LDl
3-TsH. https://t.co/3QvPqMxZSN
Links:
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
When would I use
#Aclasta vs #Prolia since #denosumab has LESS #fractures
▶️younger women with #osteoporosis requiring Rx due to long safety
▶️less wearing off when stopping it
▶️noncompliant Pts as prolia reverses effect when dose is missed
@RheumNow #EULAR2024 @eular_org https://t.co/0RTGx0sCTd
Janet Pope Janetbirdope ( View Tweet)
If your GCA flares, do you get the same features as you did at diagnosis?
20% of the time it can be new, so keep on doing the checklist!
(also, visual flares uncommon - the power of pred)
#EULAR2024 POS0110 @MayoClinic @MdWarrington @RheumNow https://t.co/hkF8vJT6HI
Links:
David Liew drdavidliew ( View Tweet)
What is better for #Rx of
#osteoporosis?
#Denosumab or ##Zoledronic acid?
#Prolia compared to #Aclasta
Giant admin US data of 125,000 Rx niaive women with #OP
▶️Prolia has LESS fractures!
POS0583 #EULAR2024 @eular_org @RheumNow https://t.co/eo1ny2VIRf
Links:
Janet Pope Janetbirdope ( View Tweet)
The art of talking about risks with our patients
https://t.co/V0JQ1EsbKc https://t.co/GSTbPu0EXZ
Dr. John Cush RheumNow ( View Tweet)
Another option for Knee Oa management? Wearable transcutaneous nerve stimulation (W-TENS) reduces the need for surgery. #EULAR2024 @rheumnow abst#POS1072 https://t.co/flcfrCrY2X
Bella Mehta bella_mehta ( View Tweet)
#EULAR2024 Please find our Day 1 & Day 2 Recap of selective abstracts/research presented at the conference 😃@RheumNow @DrMiniDey
https://t.co/AHl18gS7gF https://t.co/LEoa9rBNly
Links:
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
#EULAR2024 OP0288 Patients with Scleroderma shouldn’t be excluded from Lung Transplantation because of a concern with post-surgery complications/long term complications. Data from Italy of N=13 pts showed 93% survival, improved disesase activity & FVC over 2 years @RheumNow https://t.co/zPFB1MFxdc
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
#EULAR2024 OP0256 Phase 2 RCT ReSScue data of fecal microbiota transplantation did not meet primary endpoint (bloating & diarrhoea) in scleroderma. How about impact on faecal incontinence symptoms? This improved throughout 20wks. Could be due improved stool consistency @RheumNow https://t.co/1t7d3M5S4Z
Links:
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Some of these drugs dont seem to work in all of knee OA. I guess its really difficult to tease out different subtypes.
Subgroup analysis from a Phase 3 intraarticular JTA-004 injection at #EULAR2024 abst#Op0305 @RheumNow https://t.co/jbkLYyl93e
Links:
Bella Mehta bella_mehta ( View Tweet)
